Media Coverage
TV Documentary 'Patents or Patients?'
20 July 2011 On 20 and 27 July, the Access to Medicine Index and Wim Leereveld, are featured in a Dutch documentary about access to medicine in developing countries. Gideon Levy, an award-winning reporter, investigates how it is possible that two billion people lack access to medicine.
'Changing pharma'
4 July 2011 Interview in the July issue of 'P+' - People, Planet, Profit - the Dutch monthly magazine on corporate social responsibility, with Wim Leereveld. The theme of the magazine is the psychology behind persuasiveness. The interview with Wim focusses on his story how he convinced others of the power of the idea of the Access to Medicine Index, to catalyst change in the pharmaceutical companies and stimulate them to enhance access to medicine in developing countries.
'GSK Makes a Good Impression with Lower Priced Vaccines'
13 June 2011 Was headlined in the Dutch daily newspaper 'De Volkskrant'. The article featured the recent announcements of pharmaceutical companies GSK, Merck and Sanofi-Aventis to lower their prices of vaccines in developing countries and the first time that UNICEF publicly listed the price it pays for vaccines. The Access to Medicine Index, in the person of Wim Leereveld was asked to comment. You can find the Dutch article at 'Downloads'.
'Big Pharma Is Changing Under Pressure'
30 May 2011 On the 27th of May, 'De Volkskrant', a leading Dutch daily, reports on how pharmaceutical companies are challenged by the Access to Medicine Index to do more on access to medicine in the developing countries. Last week, May 24th, the 'Index' pharma companies gathered in Amstelveen (The Netherlands), to discuss the data collection process around the Index 2012. “Societal pressure for sustainable and social production is so high now, you have to deal with it as a company.
The Al Gore of the Pharmaceutical Industry?
26 May 2011 On May 24th, Harmke Pijpers of BNR - Business News Radio - interviewed Wim Leereveld about the Access to Medicine Index. Harmke introduced Wim to the audience as the 'Al Gore of the pharmaceutical industry', to illustrate the drive he still has after 8 years to encourage the world's largest pharma companies to do more for 2 billion people who lack access to medicine. To listen to the full interview, click here.
'Reward Big Pharma for Good Behaviour'
17 May 2011 In NRC Next, Wim Leereveld's opiniated article, on how to influence pharmaceutical companies policies and practices to increase access to medicine, was published. NRC Next is a Dutch daily, that specifically targets a younger, well educated audience. The article refers to 'Morgen 2011' (Tomorrow 2011), where Wim is one of speakers at May 21, 2011.
'Sociale farmaceut beter geleid'
13 May 2011 One of the leading Dutch newspapers, De Telegraaf, covered the news about APG and ASN Bank signing the investor statement of the Access to Medicine Index. Both APG, one of the world's largest pension asset managers and ASN Bank, the largest sustainable bank in the Netherlands, use the information in the Index when making investment decisions concerning pharmaceutical companies.
Need some help?
27 January 2011 The Dutch magazine for international development - 'Vice Versa' - gives an overview of American funding for Dutch development organizations. The Access to Medicine Foundation is mentioned as one of the organizations who receives funding from the Bill and Melinda Gates Foundation. In the article you will find an interesting graphic on the numbers of American funding in the Netherlands.
'This work really can make a difference'
21 January 2011 C2W Medicines, an independent Dutch magazine on pharmaceutical research, published a cover story in the December issue on Wim Leereveld, Chairman of the Access to Medicine Foundation. It is an inspirational story about one man's drive to make the Index a reality. "This isn't about money. The work is much more satisfying and really can make a difference."
Demonstrating Impact: Access to Medicine: Malaria Treatment
21 September 2010 Improving access to medicine can have powerful and positive effects for individuals around the world that suffer from preventable illness and disease. By simply making medicines available and cost-effective we can improve the lives of an estimated 2 billion individuals worldwide that still lack access to essential medicines. Please watch the following video and visit the Global Poverty website to understand more how improving access to medicine can save lives and reduce suffering.
Wim Leereveld Featured on NieuwWij
19 September 2010 NieuwWij is a news site dedicated to presenting people and initatives that attempt to change the world, inspire conversation and challenge perception. We invite you to view a recent video featuring Wim Leereveld and the Access to Medicine Index.
Wim Leereveld wil via Access to Medicine Index farmabedrijven mobiliseren
24 July 2010
Elk jaar in juni komen op het Pacific Health Summit internationale topbestuurders van overheden, wetenschap en bedrijfsleven bijeen om met elkaar te discussiëren over wegen en mogelijkheden die ‘de wereld gezonder maken’. Het was op dát prestigieuze podium waar Haarlemmer Wim Leereveld de tweede editie van ‘zijn’ Access to Medicine Index presenteerde.
SRI blog
13 July 2010 Henderson hosted an investor seminar in early July on the investment implications of access to medicines (AtM), a common term used to describe company efforts to ensure access to their medicines by patients who need them.
DFID
12 July 2010 Access to medicine is a basic right, yet each year millions of people die due to preventable and treatable diseases such as HIV, malaria and tuberculosis.
Brabants Dagblad
6 July 2010 Tijdens het WK-voetbal komt Afrika rechtstreeks in onze huiskamer. Soms zien we tussen de voetbalwedstrijden door iets van de ellende waarin veel Afrikanen nog steeds verkeren.
Thai PR Net
6 July 2010 เมื่อเร็วๆ นี้ จีเอสเค หรือ บริษัทแกล็กโซสมิทไคล์น ได้รับการจัดอันดับสูงสุดของดัชนีการเข้าถึงยา (The Access to Medicine Index) หรือ AMI ประจำปี พ.ศ. 2553 โดยมูลนิธิเพื่อการเข้าถึงยา (The Access to Medicine Foundation) ซึ่งเป็นองค์กรระหว่างประเทศที่ไม่แสวงหาผลกำไร มีสำนักงานใหญ่ในประเทศเนเธอร์แลนด์ มีจุดมุ่งหมายหลักคือ ความพยายามให้เกิดการพัฒนาเพื่อให้ประชาชนและผู้ป่วยในประเทศกำลังพัฒนามีการเข้าถึงยาและวัคซีนได้มากขึ้น โดยจีเอสเคได้รับการจัดอันดับสูงสุดของ AMI อีกครั้งหลังจากที่ได้เป็นครั้งแรกใน พ.ศ. 2551 มาแล้ว
Financial Daily
5 July 2010 Europe-based pharmaceuticals groups are outperforming United States and Japanese rivals in efforts to ensure medicines reach the poor, says an independent evaluation published by the Financial Times. GSK a UK-based pharmaceutical company retained its prime position in second Access to Medicines Index, Merck of US, known for its efforts on HIV and donations to treat river blindness, came next, ahead of Novartis, Gilead and Sanofi-Aventis.
WSJ Health Blog
4 July 2010 A Different Kind of Ranking: A program that assesses pharma companies according to the drug access they provide to the world’s poor gives GlaxoSmithKline, Merck and Novartis its highest rankings, the NYT reports.
DNAIndia
2 July 2010 A study by the Netherlands-based non-profit organisation Access to Medicine Foundation has highlighted that GlaxoSmithKline, Merck and Novartis are leading attempts to make medicines available to people in developing countries.
DNA India
2 July 2010
A study by the Netherlands-based non-profit organisation Access to Medicine Foundation has highlighted that GlaxoSmithKline, Merck and Novartis are leading attempts to make medicines available to people in developing countries.
Economist
2 July 2010
The Access to Medicine Index,
which is funded by governments and charities, including the Gates foundation, published a study on the efforts of 27 drug companies to provide medicine to the developing world.
Bill Gates-What I'm Thinking
2 July 2010 For people suffering from serious but treatable diseases like pneumonia and tuberculosis, access to drugs can mean the difference between life and death. A new report and two recent announcements are signs of progress in efforts to expand access.
Policy and Medicine
2 July 2010 Recent settlements, hearings, legal cases and congressional investigations have overshadowed one of the most important roles pharmaceutical companies play in the world: making their products available to the world’s poor.
The New York Times
28 June 2010 GlaxoSmithKline, Merck and Novartis have taken the top three spots again on the Access to Medicine Index, which ranks pharmaceutical companies on how readily they make their products available to the world’s poor.
International Herald Tribune
30 June 2010 GlaxoSmithKline, Merck and Novartis have taken the top three spots again on the Access to Medicine Index, which ranks pharmaceutical companies on how readily they make their products available to the world’s poor.
prSalud
30 June 2010 Es el número 1 según el ranking 'Access to Medicina Index 2010´. Prsalud ha hablado con Pedro Cano, director de Comunicación de GlaxoSmithKline (GSK) y con responsables de otras farmacéuticas que siguen entre los 10 primeros de la lista.
The Hindu
30 June 2010 GlaxoSmithKline, Merck and Novartis have taken the top three spots again on the Access to Medicine Index, which ranks pharmaceutical companies on how readily they make their products available to the world's poor. It was the second time the rankings, which were created in 2008, have been issued. This time, 95 per cent of the brand-name companies approached by the Dutch foundation that started the index agreed to provide information; two years ago, only about half did.
Le Figaro
28 June 2010 D'après le magazine américain Barron's, le secteur subirait un abandon injustifié des investisseurs à Wall Street. Les groupes européens seraient notamment plus intéressants que leurs homologues américains.
Le Journal des Finance
28 June 2010 D’après le magazine américain Barron’s, le secteur subirait un abandon injustifié des investisseurs à Wall Street. Les groupes européens seraient notamment plus intéressants que leurs homologues américains.
EuropaPress
28 June 2010 El laboratorio GlaxoSmithKline (GSK) es la empresa más responsable y comprometida con labores humanitarias por el envío continuado de medicamentos a los países en vías de desarrollo, según el ranking 2010 'Access to Medicine Index'.
acceso
28 June 2010 GlaxoSmithKline (GSK) ha sido distinguida por el “Access to Medicine Index” como la empresa farmacéutica más responsable y comprometida del sector en labores humanitarias por el envío continuado de medicamentos a los países en vías de desarrollo. Este prestigioso ranking, que analiza los esfuerzos que realizan las principales compañías en este sector, ha situado a GSK en el primer lugar del ranking.
South Asian Medianet
28 June 2010 Karachi, June 28 -- London: Europe-based pharmaceuticals groups are outperforming United States and Japanese rivals in efforts to ensure medicines reach the poor, says an independent evaluation published by the Financial Times.
Health Reform Watch
28 June 2010 Earlier this week, the Access to Medicine Foundation released its 2010 Access to Medicine Index, “a ranking of the world´s largest pharmaceutical companies on their efforts to increase access to medicine for societies in need.”
Zunia
28 June 2010 The Access to Medicine Foundation’s major initiative is the Access to Medicine Index, which analyzes and ranks the access to medicine efforts of the world’s largest pharmaceutical companies. The Access to Medicine Index 2010 ranks 27 pharmaceutical companies on their efforts to provide access to medicines, vaccines and diagnostic tests to people living in 88 countries.
de Volkskrant
27 June 2010 De farmaceutische industrie stelt het patentrecht boven alles. Maar steeds vaker speelt de maatschappelijke verantwoordelijkheid ook een rol.
discapnet
25 June 2010 GlaxoSmithKline, Merck & Co y Novartis son las farmacéuticas más responsables de acuerdo con el Acces to Medicine Index que analiza los esfuerzos que hacen las 20 empresas más grandes del sector en llevar las medicinas a los países en desarrollo, según se conoció este lunes.
Burril Report
25 June 2010 Global ranking shows more transparency and more programs for making drugs available to people in developing nations.
“The Index unveils great improvements, especially in the areas of research and development, and equitable pricing. At the same time, it shows that the industry as a whole still has a long way to go.”
SocialFunds
23 June 2010 Access to Medicine Foundation Publishes 2010 Access to Medicine Index
by Robert Kropp
The new index improves upon the 2008 version by including more pharmaceutical companies and by shifting focus from policy to practice.
SocialFunds.com -- There is widespread agreement that an essential part of the corporate social responsibility (CSR) of pharmaceutical companies is providing access to medicine for neglected diseases in developing countries.
PharmaTech
24 June 2010 European pharmaceutical companies are outdoing their US counterparts when it comes to making medicines available to developing countries, according to the Access to Medicine Index, which analyzes and ranks the access-to-medicine efforts of the world’s largest pharmaceutical companies.
Novo Nordisk Press Release on The AtM Index 2010
22 June 2010 Innovative approach to access to diabetes care recognised in global ranking
In the 2nd Access to Medicines Index (ATMI), released in Amsterdam Monday 21 June, Novo Nordisk ranks 8th among 20 research-based pharmaceutical companies. The ATMI ranks the world's largest drug originator and generics companies on their efforts to make sure that medicines are made for, and reach, people in low and medium-income countries. The benchmark is made on the basis of company commitments, transparency, performance and innovation.
CSL Recruitment
23 June 2010 GSK tops 2010 Access to Medicines Index
GlaxoSmithKline (GSK) has been named as the global pharmaceutical industry leader in terms of conducting clinical research which prioritises the needs of developing nations.
The UK-based company has been ranked top of the second Access of Medicines Index, which has been compiled by the not-for-profit organisation Access to Medicine Foundation to ensure that treatments are made for needy populations in poorer countries.
Top News Arab Emirates
23 June 2010 European Drug Makers Outnumber US Counterparts in Top 10 List
According to a new report based on the Access to Medicines Index, the preference the European drug producers had been enjoying over the US equivalents has faded off in over the last two years. The figures observed in the AMI, which has been released for the second time after 2008, was resultant of a joint effort made by as many as 22 institutional investors and fund managers.
The Medical News
23 June 2010 European drugmakers lead in making medicines available to developing world, Index says
European drug companies came out ahead of their U.S. counterparts in making medicines available to people in developing countries, but their lead is beginning to shrink, according to the Access to Medicines Index (AMI), released on Monday, Reuters reports (Kelland, 6/21).
The Henry J. Kaiser Family Foundation
22 June 2010 European Drugmakers Lead In Making Medicines Available To Developing World, Index Says
European drug companies came out ahead of their U.S. counterparts in making medicines available to people in developing countries, but their lead is beginning to shrink, according to the Access to Medicines Index (AMI), released on Monday, Reuters reports (Kelland, 6/21).
NRP Health blog
22 June 2010 American Drugmakers Improve Access In Developing World, But Lag Europeans
The Europeans have the Americans beat. But lucky for World Cup enthusiasts, it's not a soccer defeat.
European drugmakers outperformed American companies in making medicines available to poor people in developing countries, according to the second edition of an index that was released yesterday by the Dutch Access to Medicine Foundation.
Ethiopian Review
22 June 2010 Europe’s drugmakers beat U.S. on access for poor
The Access to Medicines Index (AMI) – released this week for the second time since its launch in 2008 – is produced by a Dutch-based foundation and backed by 22 institutional investors and fund managers, who together manage $3.1 trillion in assets.
It put Britain's GlaxoSmithKline at the top of its list of 20 of the world's largest pharmaceutical companies, ranked on the efforts to make sure medicines are made for, and reach, people in developing countries.
Top News Singapore
22 June 2010 Europe still bigger on the drug market says research
The gap between drug makers in the United States and Europe has been decreasing but European drug makers are still ahead on the rat race. The research by the Access to Medicines Index released its second edition since 2008 published the findings. AMI which is Dutch based is supported by 22 investors and has a value of over $3.1 trilion.
The Hindu Business Line
22 June 2010 Access Index: Generic drug makers less transparent in developing nations
Generic drug-makers are less transparent about programmes to make medicines accessible to people in developing countries than originator companies in Europe and the US, says the second Access to Medicine (ATM) Index.
The ATM Index is created by the Access to Medicine Foundation, a Netherlands-based non-profit, and researched by RiskMetrics ESG Analytics, part of MSCI Inc, a global provider of investment decision support tools.
MedCity News
23 June 2010 GSK, friend to the poor:
GlaxoSmithKline tops the Access to Medicine Index, which is designed to offer investors a way to compare drugmakers' social responsibility records by measuring 106 indicators such as philanthropy, patents, pricing and management.
MedCity News
Pharmabiz
22 June 2010 Ranbaxy, Cipla enter in the list of Access to Medicine Index
European pharmaceutical companies outcompete their US counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released yesterday.
According to Access to Medicine Index, two Indian generic drug makers Ranbaxy Laboratories and Cipla, who do less research but produce low-cost off-patent drugs, now have a separate ranking in the top list.
Zenopa
22 June 2010 GlaxoSmithKline recognised for medicines access initiatives
GlaxoSmithKline has been named as the pharmaceutical industry leader in terms of making its medicines accessible to patients in developing nations.
The UK-based company has topped the Access to Medicine Foundation's second Access of Medicines Index, maintaining its leadership position from the original 2008 ranking.
Pharmalot
21 June 2010 Which Drugmaker Does The Most For The Poor?
And the answer is.... GlaxoSmithKline, which led its counterparts in a host of variables that formed the second-ever Access to Medicine Index. European drugmakers, in fact, bested US rivals in making medicines available to people in developing countries, although the foundation that runs the project says this lead is shrinking.
Medical News Today
23 June 2010 European Drugmakers Lead In Making Medicines Available To Developing World, Index Says
European drug companies came out ahead of their U.S. counterparts in making medicines available to people in developing countries, but their lead is beginning to shrink, according to the Access to Medicines Index (AMI), released on Monday, Reuters reports (Kelland, 6/21).
rcm pharma
23 June 2010 Índice revela o que laboratórios fazem para tornar fármacos acessíveis
Dois biliões de pessoas não têm acesso aos medicamentos de que precisam. Muitos nos países em desenvolvimento não podem pagar por fármacos contra doenças como a malária ou o HIV.
India Business Insight
23 June 2010 Access Index Generic Drug makers less transparent in developing nations (Ranbaxy, Cipla and Dr. Reddy's topped the list)
AVRO De Praktijk radio studio discussion
21 June 2010 A studio discussion following publication of the Index 2010. Guests included Index founder Wim Leereveld. "Europese farmaceuten voelen zich verantwoordelijker voor het gebrek aan medicijnen in de armste ontwikkelingslanden dan Amerikaanse. Dat blijkt uit de vandaag gepresenteerde Access to Medicine Index, een ranglijst van twintig farmaceuten die aangeeft hoe farmaceuten medicijnen voor arme landen toegankelijk maken.
RNW
21 June 2010 Drug companies have a heart too - check the index
Two billion people have no access to the medicines they need. Many in the developing world can't afford drugs to fight diseases like malaria or HIV/AIDS.
It's a common perception that pharmaceutical companies are to blame. Now there's a tool that reveals how much - or little - they're actually doing about the problem: the Access to Medicine Index - developed by Dutchman Wim Leereveld.
Radio Interview BNR Nieuwsradio
21 June 2010 Europese maker van medicijnen doen meer voor arme landen dan hun concurrenten in de Verenigde Staten. Vergeleken met 2008 gaven farmabedrijven nu veel meer inzicht in hun werk op dit gebied. Radio interview met voorzitter van de Access to Medicine Foundation Wim Leereveld.
Global Times
22 June 2010 European drug makers still outrank their US counterparts in making medicines available to poor people, but the lead they established two years ago is starting to shrink, according to a new analysis.
Big Job Blog
22 June 2010 Pharmaceutical and biotechnology companies like to distinguish themselves from companies that manufacture consumer products because their products have the potential to save the lives of patients suffering from a plethora of illnesses.
THE BIG RED BIOTECH BLOB
22 June 2010 This post from the Pharmalot blog details companies that have done the most to make drugs available to developing companies. Not surprisingly (to me anyway), European companies led their US counterparts. The number one company was GSK.
China Post
22 June 2010
European drugmakers still outrank their U.S. counterparts in making medicines available to poor people, but the lead they established two years ago is starting to shrink, according an analysis published on Monday.
iStockAnalyst
22 June 2010
Generic drug-makers are less transparent about programmes to make medicines accessible to people in developing countries than originator
Dream Drug (Korean)
22 June 2010 유럽 제약사들이 미국 제약사에 비해 가난한 사람들이 사용할 수 있는 약물을 더 많이 생산하고 있다는 분석 결과가 21일 발표됐다.
CNBC
8 July 2010 Many people living in poverty do not have enough food or clean water, never mind access to a functioning health care system.
BioValley Basel
22 June 2010 The Access to Medicines Index (AMI) - released this week for the second time since its launch in 2008 - is produced by a Dutch-based foundation and backed by 22 institutional investors and fund managers, who together manage $3.1 trillion in assets.
Leidsch Dagblad
21 June 2010 Haarlem - Merck Sharpe & Dohme (MSD), de Amerikaanse geneesmiddelenreus waarvan het Europese hoofdkwartier gevestigd is in Haarlem, scoort vandaag een tweede plaats op de nieuwe Access to Medicine Index 2010.
Reuters U.K.
21 June 2010 By Kate Kelland, European drugmakers still outrank their U.S. counterparts in making medicines available to poor people, but the lead they established two years ago is starting to shrink, according an analysis published on Monday.
Responsible Investor
20 June 2010 First ATM ranking for generic drug companies by Hugh Wheelan Pharmaceutical companies have taken notable steps in improving the transparency and reach of drugs available for use in developing countries, according to the 2010 Access to Medicine Index (ATM).
De Volkskrant
21 June 2010 AMSTERDAM - Amerikaanse farmaceutische bedrijven spannen zich steeds meer in om ook de allerarmsten ter wereld aan medicijnen te helpen. Ze lopen de achterstand op hun Europese collega’s langzaam in. Dit blijkt uit de Access to Medicine Index, die voor de tweede keer is gepubliceerd.
The Guardian
21 June 2010 By Kate Kelland
LONDON, June 21 (Reuters) - European drugmakers still outrank their U.S. counterparts in making medicines available to poor people, but the lead they established two years ago is starting to shrink, according an analysis published on Monday.
Financial Times
21 June 2010 By Andrew Jack in London, Europe-based pharmaceuticals groups led by GlaxoSmithKline are outperforming US and Japanese rivals in efforts to ensure medicines reach the poor, according to an independent evaluation published on Monday.
Journal of India
6 July 2010 European Drug Companies lead 'Access to Medicine Index'
India Business Newsweekly
6 July 2010 European Drug Companies lead 'Access to Medicine Index'
Asian Business Newsweekly
6 July 2010 European Drug Companies Lead 'Access to Medicine Index'
De Gooi en Eemlander
21 June 2010 Haarlem - Merck Sharpe & Dohme (MSD), de Amerikaanse geneesmiddelenreus waarvan het Europese hoofdkwartier gevestigd is in Haarlem, scoort vandaag een tweede plaats op de nieuwe Access to Medicine Index 2010.
Guardian.co.uk
2 July 2010 LONDON, June 21 (Reuters) - European drugmakers still outrank their U.S. counterparts in making medicines available to poor people, but the lead they established two years ago is starting to shrink, according an analysis published on Monday.
E-drug
21 July 2010 European pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
GNT: Generation Nouvelles Technologies
21 June 2010 Le classement mondial montre plus de transparence et plus de programmes destinés aux pays à faibles revenus
Les compagnies pharmaceutiques européennes l'emportent sur leurs homologues américains lorsqu'il s'agit de rendre les médicaments accessibles aux pays en voie de développement, mais leur avance diminue, selon la seconde édition de l'Access to Medicine Index parue aujourd'hui.
FOREXYARD
21 June 2010
European drugmakers still outrank their U.S. counterparts in making medicines available to poor people, but the lead they established two years ago is starting to shrink, according an analysis published on Monday.
Asianet
21 June 2010 Indian Firms Less Open About Efforts for Low-income Countries Than Originator Companies
10KLFY TV
21 June 2010 European pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
Scientific Blogging
21 June 2010 For the first time, Japanese pharmaceutical companies were ranked with their U.S. and European counterparts on a global Index comparing companies' efforts to make medicines available to the people in developing countries. Overall, European drug companies are leading in this area, according to the second Access to Medicine Index released today.
PharmacyChoice
21 June 2010 European pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
World News Report
21 June 2010 European pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
PR Hub
21 June 2010 For the first time, Japanese pharmaceutical companies were ranked with their U.S. and European counterparts on a global Index comparing companies' efforts to make medicines available to the people in developing countries.
StreetInsider
21 June 2010 Amsterdam /PRNewswire/ -- European pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
The Chronicus Post
21 June 2010 European pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
AsiaPRNews
20 June 2010 For the first time, Japanese pharmaceutical companies were ranked withtheir U.S. and European counterparts on a global Index comparing companies’ efforts to make medicines available to the people in developing countries. Overall, European drug companies are leading in this area, according to the second Access to Medicine Index released today.
The Medical News
21 June 2010 European pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
Biz Journals
21 June 2010 European pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
cbs4denver.com
21 June 2010 European pharmaceutical companies out compete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
BBNEWS
21 June 2010 Aids activists will hold a rally outside Bristol-Myers Squibb’s plant in France this week in protest over the halt in production of an essential HIV drug for children, as a new league table shows BMS well down the rankings among pharma companies that help the poor to access their medicines
EuroInvestor
2 July 2010 Independent Ranking Shows More Transparency, More Programs for Low-income CountriesEuropean pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
Trouw
21 June 2010 Amsterdam - Vrijwel alle grote fabrikanten van merkmedicijnen geven openheid van zaken over hun maatschappelijk activiteiten in arme landen. Fabrikanten van merkloze medicijnen hebben daar meer moeite mee.
Digital Journal
21 June 2010 European pharmaceutical companies out compete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
Noordhollands Dagblad
21 June 2010 Haarlem - Merck Sharpe & Dohme (MSD), de Amerikaanse geneesmiddelenreus waarvan het Europese hoofdkwartier gevestigd is in Haarlem, scoort vandaag een tweede plaats op de nieuwe Access to Medicine Index 2010.
pharma news eu
21 June 2010 Generic drug makers are less transparent about programs to make medicines available to people in developing countries than originator companies in Europe and the United States. Overall, European drug companies are leading in this area, according to the second Access to Medicine Index released today.
Guardian blog
21 June 2010 Sarah Bosely's Global Health Blog
Rally planned over drug company Aids plant closure.
Aids activists will hold a rally outside Bristol-Myers Squibb's plant in France this week in protest over the halt in production of an essential HIV drug for children, as a new league table shows BMS well down the rankings among pharma companies that help the poor to access their medicines.
RMG ESG Insight
16 June 2010 'An Unbalanced View of Company Behavior is a Risk for Innovation': A Conversation with Wim Leereveld of the Access to Medicine Foundation
By Alan Petrillo
[Ed. Note – On June 21, Access to Medicine Index 2010, which ranks major global pharmaceutical companies on their efforts to increase global access to medicine, will be released to the public. Index 2010 is an initiative of the Access to Medicine Foundation, a Netherlands-based non-profit organization dedicated to improving access to medicines to societies in need.
Sys.com Online
4 July 2010 For the first time, Japanese pharmaceutical companies were ranked with their U.S. and European counterparts on a global Index comparing companies' efforts to make medicines available to the people in developing countries. Overall, European drug companies are leading in this area, according to the second Access to Medicine Index released today.
Yacht Vacations & Charters
4 July 2010 European pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
EuroInvestor
20 June 2010 European Drug Companies Lead 'Access to Medicine Index'
Independent Ranking Shows More Transparency, More Programs forLow-income Countries.
European pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
PR Newswire
20 June 2010 European Drug Companies Lead 'Access to Medicine Index'
Independent Ranking Shows More Transparency, More Programs for Low-income Countries
AMSTERDAM, June 20, 2010 /PRNewswire/ -- European pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
StreetInsider
20 June 2010 European Drug Companies Lead 'Access to Medicine Index'
Independent Ranking Shows More Transparancy, More Programs For Low-income Countries
AMSTERDAM /PRNewswire/ -- European pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
FinanzNachrichten
21 June 2010
Europäische Arzneimittelhersteller
Europäische Pharmaunternehmen schlagen ihre Gegenspieler aus den USA aus dem Feld, wenn es darum geht, Medikamente für Menschen in Entwicklungsländern zugänglich zu machen, doch der Vorsprung wird klein
RedLightRevolt
20 June 2010 European pharmaceutical companies out compete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
ADVFN
20 June 2010
European Drug Companies Lead 'Access to Medicine Index'
European pharmaceutical companies outcompete their U.S.
Chicago Press Release Services
20 June 2010 European pharmaceuticalcompanies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
Epicos
20 June 2010 European pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
NewsGnomes
20 June 2010 European pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
Presseportal
20 June 2010 Europäische Pharmaunternehmen schlagen ihre Gegenspieler aus den USA aus dem Feld, wenn es darum geht, Medikamente für Menschen in Entwicklungsländern zugänglich zu machen, doch der Vorsprung wird kleiner, wie die heute veröffentlichte zweite Ausgabe des Access to Medicine Index zeigt.
BioTech finances
20 June 2010 Independent Ranking Shows More Transparency, More Programs for Low-income Countries
European pharmaceutical companies out compete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
RedOrbit
20 June 2010 European pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
NewsBlaze
20 June 2010 European pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
BioPortfolio
20 June 2010 European pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
Pressemitteilungen
20 June 2010 Europäische Pharmaunternehmen schlagen ihre Gegenspieler aus den USA aus dem Feld, wenn es darum geht, Medikamente für Menschen in Entwicklungsländern zugänglich zu machen, doch der Vorsprung wird kleiner, wie die heute veröffentlichte zweite Ausgabe des Access to Medicine Index zeigt.
Personalized Medicine
20 June 2010 European pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their leadis shrinking, according to the second Access to Medicine Index, releasedtoday.
FOX Business
20 June 2010
European pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
FirstWord
20 June 2010
According to the Access to Medicine Index, which ranks the world's top pharmaceutical companies on their efforts to ensure that drugs are available to people in developing countries, six of the ten highest-ranking drugmakers that lead access to medicine were based in Europe in 2010, while four were US-based. In 2008, seven of these drugmakers were in Europe.
PR Hub
20 June 2010 Generic drug makers in general are less transparent about programs to make medicines available to people in developing countries than originator companies in Europe and the United States.
PR Hub
20 June 2010 European pharmaceutical companies outcompete their U.S. counterparts in making medicines available to people in developing countries, but their lead is shrinking, according to the second Access to Medicine Index, released today.
Responsible Investor
3 May 2010 Access to medicines: a vested interest for investors and companies
For nearly three years investors have been pre-occupied with the credit crunch and the global financial crisis, which have bequeathed to taxpayers a mountain of debt. In 2009, the US deficit soared to $1.4 trillion, in the UK, government support for the banking system reached £850 billion.
Radio 1
26 March 2010 Hoe krijg je goedkope medicijnen naar ontwikkelingslanden
Audio of the interview with Wim Leereveld on Radio 1
Nefarma
22 March 2010 Het juiste initiatief op het juiste moment
In juni van dit jaar verschijnt de tweede editie van de Access to Medicine Index. De index bracht twee jaar geleden voor het eerst in kaart welke inspanningen grote geneesmiddelenfabrikanten verrichten om arme mensen toegang te geven tot medicijnen en vaccins.
Onze Wereld
15 March 2010 Index brengt medicijn dichterbij de armsten
Financial Times
12 March 2010 Patients’ groups distrust ‘big pharma’
The majority of patients’ organisations consider pharmaceutical companies untrustworthy, according to a survey conducted by a UK-based consultancy to be released on Friday.
Nieuwsbank
10 March 2010 Access to Medicine Index 2010 wordt in juni gepubliceerd
Ethical Performance
11 February 2010 Major Index goes missing as firms hit by overload
A high profile annual social responsibility index of pharmaceuticals companies has failed to appear because of wranglings over the ‘extraordinary’ amounts of data the business have been asked to provide.
The International Herald Tribune
11 February 2010 Andrew Witty is not quite as young or as buff as Anderson Cooper, but he does do interviews in shirtsleeves from the slums of Nairobi and rural hospitals in Uganda.
The International Herald Tribune
11 February 2010 Andrew Witty is not quite as young or as buff as Anderson Cooper, but he does do interviews in shirtsleeves from the slums of Nairobi and rural hospitals in Uganda.
The New York Times
8 February 2010 GlaxoSmithKline, ranked number one on the first Access to Medicine Index. Today, the company has made significant corporate commitments towards improving its access to medicines policies throughout the developing world and improving the health and well-being of those in need. Read the article.
The Seattle Times
8 February 2010 THE Bill & Melinda Gates Foundation's $10 billion investment in childhood vaccines is breathtaking in scale and its promise for bolstering gains in childhood health.
New Scientist
30 September 2009 Pharma Chameleons
IF SCIENTISTS want to do good for the developing world, it’s hard to think of an industry where they’re going to make more of a contribution.” So says Guy Willis, director of communications at the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) in Geneva, Switzerland.
Interfaith Center on Corporate Responsibility
28 September 2009 Unequal Access: The struggle to Deliver Health Care in Emerging Markets
De Volkskrant
17 July 2009 Farmaceut prijzen die goed doet
De Nederlandse Access to Medicine Index probeert farmaceutische bedrijven te stimuleren hun medicijnen toegankelijk te maken voor ontwikkelingslanden. Bill Gates is zo enthousiast dat hij de index sponsort.
De Telegraaf
16 July 2009 Gates steunt Haarlems initiatief
Haarlems Dagblad
16 July 2009 Bill Gates sponsort initiatief uit Haarlem
De liefdadigheidsorganisatie van multimiljardair Bill Gates gaat een succesvol Haarlems humanitair initiatief financieren. Met geld van de Bill & Melinda Gates Foundation wint Access to Medicine van Haarlemmer Wim Leereveld aan status en dus aan effectiviteit.
Het Parool
16 July 2009 Bill Gates stapt in medicijnindex
Haarlems Dagblad
15 July 2009 Haarlemmer Wim Leereveld knijpt zich in arm, maar Bill Gates helpt werkelijk.
Pharmaceutical Marketing
3 July 2009 Gaining Access: Philanthropic initiatives ensure pharma a seat at the table shaping healthcare deliveryAccess to Medicines initiatives should be considered more than just exercises in corporate philanthropy. Far-sighted organisations realise that by engaging in these inititiatives not only can they play a greater role in shaping healthcare delivery, but they can increase their access to customers as well.
www.justmeans.com
5 June 2009 Sustainable Finance: Access to Medicine Index
One of the more interesting examples in recent years is the Access to Medicine Index (ATMI). While in The Netherlands, I took the train to Haarlem to meet the founder, Wim Leereveld, in a renovated office with a fine table from old wood and large windows by the canal. The Access to Medicine Index points the world’s largest pharmaceutical companies to help solve this global crisis.
www.snsreaal.nl
28 April 2009 SNS steunt internationale projecten waaronder de Access to Medicine Index
Pharmaceutical Executive Digest Europe
21 March 2009 The million dollar question
Gerhard Symons realises that just one simple question: “to whom is a pharmaceutical company responsible?”, can expose complex tensions between short-term profit motive, long-term market building and perception management of the industry.
The Lancet (U.K.)
20 December 2008 The new Access to Medicine Index
A letter to the editor from the Access to Medicine Foundation responding to earlier correspondence from Health Action International.
The Lancet Inf. Diseases (U.K.)
14 September 2008 Global initiatives to promote wider access to medicines
At least a third of the world’s population lacks essential, effective medicines, particularly for infectious diseases, such as HIV and malaria. Now, various initiatives have been launched or will soon become operational that promise to tackle obstacles involved in the chain from manufacture to local supply.
The Lancet (U.K.)
13 September 2008 The new Access to Medicine Index
The Access to Medicine Foundation’s new index set out to improve access to medicines through a transparent, quantifiable comparison of corporate social responsibility for 20 pharmaceutical companies. (Two letters in ‘Correspondence’)
Ethical Performance (U.K.)
12 September 2008 New ranking may be unpopular, but it’s here to stay
Pharmaceutical companies are not happy, but a number of influential investors have expressed their support for the Access to Medicine Index.
Nefarma& (The Netherlands)
9 September 2008 Betere zorg voor twee miljard
Voor twee miljard mensen is betaalbare gezondheidszorg ontoegankelijk. Farmaceutische bedrijven kunnen veel betekenen om de gezondheidszorgvoor hen beter bereikbaar te maken, mits ze erkend worden in hun bijdrage..
Onze Wereld (The Netherlands)
1 September 2008 'Medicijnen moeten over de hele wereld beschikbaar zijn'
Deze zomer werd de Access to Medicine Index gepresenteerd, een meetlat voor de inzet van farmaceutische bedrijven om medicijnen wereldwijd betaalbaar te maken.
CMAJ (Canada)
26 August 2008 Big pharma and good corporate citizenship
The impact of company policies on the availability of patented products in poor countries is largely unknown and it’s all but a total mystery as to how much of a company’s research budget is spent on discovering cures for diseases that affect the poor. Until now, that is…
Chicago Public Radio (U.S.)
4 August 2008 Access to Medicine in the Developing World
Audio (mp3) of a 5 minute interview by Jerome McDonnell, host of the Worldview program, with Wim Leereveld.
The Gazette (Canada)
31 July 2008 Transparency is key to making HIV drugs accessible to those who need them
This month the global community will converge at the International AIDS Conference in Mexico City. Despite an enormous amount of worldwide attention, an estimated 33.2 million people in the world remain afflicted with AIDS.
TIME magazine (U.S.)
31 July 2008 Bill Gates: Making Capitalism More Creative
In a piece on ‘Creative Capitalism’, Microsoft Chairman Bill Gates holds up the Access to Medicine Index as an example: “..This summer, a Dutch nonprofit called the Access to Medicine Foundation started publishing a report card that shows which pharmaceutical companies are doing the most to make sure that medicines are made for — and reach — people in developing countries.”.. Read full article online
ComunicaRSE (Argentina)
15 July 2008 Ranking sobre las políticas de los laboratorios para el sumnistro de fármacos a los países más pobres
Un ranking elaborado por la fundación holandesa Access to Medicine, ha señalado aquellos laboratorios que cuentan con mejores políticas de suministro de fármacos a los países más pobres, según informa el portal Atmindex.org.
MediaGlobal (U.N.)
7 July 2008 MSF says pharmaceutical companies not doing enough to fight AIDS and TB
..Last month, the Access to Medicine Foundation launched the Access to Medicines Index, a comprehensive listing of the pharmaceutical companies that have worked the most to increase access to medicines for all…
The Sunday Times (Sri Lanka)
6 July 2008 GSK ranked No 1 on first ‘Access to Medicine’ Index
The first Access to Medicine (ATM) Index developed by the Access to Medicine Foundation, an independent international non-profit organization, has ranked GlaxoSmithKline (GSK) as the current industry leader when it comes to improving access to drugs and accines in low income countries, GSK’s local office said in a press release.
Het Parool (The Netherlands)
5 July 2008 Medicijnen voor Afrika
Ontwikkelingslanden moeten het vaak zonder medicijnen stellen. Een ranglijst van de inzet van farmaceuten om de bevolking te helpen, moet aansporen tot meer actie.
Basler Zeitung (Switzerland)
25 June 2008 Big Pharma hilft der Dritten Welt
Der fehlende Zugang zu verlässlichen und erschwinglichen Medikamenten und Impfstoffen kostet welweit jährlich zehn Millionen Menschen das Leben. Eind niederländischen Stiftung hat nun einen Index über das Engagement der 20 grössten Pharmakonzerne in Entwicklungsländern erstellt.
Intellectual Asset Management Magazine blog
24 June 2008 GSK leads the world in access to medicine rankings as generic companies trail
GlaxoSmithKline, Novo Nordisk and Merck & Co are the three major life science companies doing most to promote access to medicine in the developing world, a recently released study has found.
Apotheke Adhoc (Germany)
24 June 2008 Europäische Firmen sind engagierter
Pharmafirmen übernehmen einer Studie zufolge mehr soziale Verantwortung. Dabei schneiden insbesondere europäische Unternehmen im Vergleich gut ab.
Financial Times
23 June 2008 'Not a true picture of access to crucial treatment'
A letter to the editor of the Financial Times from Tim Reed, Director, Health Action International Global, Amsterdam, The Netherlands.
Financial Times
23 June 2008 'Medicines index is deeply flawed'
A letter to the editor of the Financial Times from Mr Robert L. Mallett, President of the Pfizer Foundation and senior vice-president, WW Alliance Development, Philanthropy & Corporate Responsibility, Pfizer Inc, New York, NY, USA.
Spicy IP (India)
21 June 2008 The Access to Medicine Index released - Ranking Pharmaceutical Companies
Starting from the Pretoria patent litigation in South Africa to the Novartis patent litigation in Chennai last year the big pharmaceutical companies in the world have endured a particularly brutal image bashing exercise….
Trouw (The Netherlands)
20 June 2008 'Gedragsindex over farmaceuten is zwak'
De nieuwe index over het gedrag van farmaceuten gaat te veel over de theorie en te weinig over de praktijk, zegt een consumentenorganisatie.
Financial Express (India)
20 June 2008 Cipla, Ranbaxy at bottom in top 20 pharma firms’ survey
The domestic pharma majors, Cipla and Ranbaxy, have ranked at number 16 and 17 respectively among the 20 international pharma Companies that were evaluated by the Netherlands-based “Access to Medicine Index” for the year, 2008.
Financial Times
20 June 2008 A way to rank access to medicines
A letter to the editor of the Financial Times from Mr Jeremiah Norris, Director, Center for Science in Public Policy, Hudson Institute, Washington, DC.
Science (U.S.)
19 June 2008 Rating Big Pharma
This week, the Access to Medicine Foundation, a charity based in the Netherlands, issued its first ranking of 20 pharmaceutical companies’ efforts to make key medicines available to the world’s poor.
International Herald Tribune
18 June 2008 A new ranking for pharmaceutical companies' efforts in the third world
An unusual ranking of pharmaceutical companies is being unveiled this week.
Trouw (The Netherlands)
17 June 2008 Nederlander neemt farmaceuten de maat
Een Nederlandse index peilt voor het eerst het maatschappelijk gedrag van farmaceutische bedrijven. „Ik moest snel mijn boeltje pakken.”
Le Monde (France)
17 June 2008 Les pays pauvres, nouvel enjeu pour les laboratoires
Les laboratoires pharmaceutiques européens font plus d’efforts que les américains pour aider les pays pauvres à accéder aux médicaments. C’est ce qui ressort du classement publié, lundi 16 juin, par la fondation néerlandaise Access to medicine en collaboration avec l’organisme d’études spécialisé, Innovest.
New York Times (U.S.)
17 June 2008 Index Ranks Pharmaceutical Groups According to Third World Outreach
An unusual ranking of pharmaceutical companies is being unveiled this week. It evaluates them by how easy they make it for patients in poor countries to get drugs and vaccines.
BNR Nieuwsradio (The Netherlands)
17 June 2008 Interview Wim Leereveld
Audio of the interview with Wim Leereveld about the launch of the Index.
Gazet van Antwerpen (Belgium)
17 June 2008 Europese farmabedrijven meest begaan met arme landen
Europese geneesmiddelenbedrijven doen meer om de toegang tot medicijnen in arme landen te verbeteren dan hun Amerikaanse concurrenten. Dat blijkt uit een rangschikking van farmafirma’s die de Nederlandse stichting Access to Medicine maakte, als leidraad voor investeerders die hun geld duurzaam willen beleggen.
FEM Business (The Netherlands)
17 June 2008 Glaxo heeft oog voor armen
Van de grote farmaciebedrijven doet het Britse GlaxoSmithKline het meest om medicijnen toegankelijker te maken voor arme landen. Europese farmaceuten doen meer aan dat probleem dan Amerikaanse.
Financial Times
16 June 2008 GSK leads pack in bringing drugs to the poor
European pharmaceutical companies – led by GlaxoSmithKline – outperform their US peers in efforts to make medicines available and affordable to the poor, according to an analysis to be released today.
Volkskrant (The Netherlands)
16 June 2008 'Ze kunnen miljoenen levens redden'
Een Nederlandse index peilt voor het eerst het maatschappelijk gedrag van farmaceutische bedrijven. „Ik moest snel mijn boeltje pakken.”
The Guardian (U.K.)
16 June 2008 European firms beat U.S. on drug access for poor
European drug makers are better than their U.S. counterparts in ensuring medicines reach people in poor countries, with Britain’s GloxoSmithKline leading the field, according to an analysis on Monday.
New Scientist (U.K.)
16 June 2008 GSK tops new ethical ranking for investors
A new rating of 20 of the world’s biggest pharmaceutical companies by how ethically they treat the poor has given Britain’s GlaxoSmithKline top marks, followed by Denmark’s Novo Nordisk and Merck of the U.S.
Haarlem 105 (The Netherlands)
16 June 2008 Top-20 gepubliceerd van farmaceutische multinationals
Audio (mp3) of a five-minute radio interview with Wim Leereveld, Chair of the Access to Medicine Foundation.
Citywire (U.K.)
16 June 2008 GSK leads new index on access to medicine
GlaxoSmithKline (GSK) leads a new global index launched today that ranks pharmaceutical companies on their efforts to provide medicine to people at risk from poverty-related diseases such as malaria, tuberculosis and HIV/AIDS.
Smartbrief (U.S.)
16 June 2008 Study: European firms outperform peers in drug-access efforts
European drugmakers have edged out other pharmaceutical firms in efforts to make treatments accessible and affordable to impoverished patients, according to an analysis by the Access to Medicines Index.
BBC World
16 June 2008 Interview Wim Leereveld
Audio of the interview with Wim Leereveld about the launch of the Index.
Financial Times Deutschland (Germany)
16 June 2008 Medikamente für Arme kommen aus Europa
Europas Pharma-Hersteller tun mehr für die Armen der Welt als ihre US-Konkurrenten. Das hat eine Studie ergeben, die am Montag veröffentlicht wird – trotz scharfen Widerstands in der Branche.
Intermediair (The Netherlands)
12 June 2008 'We kunnen niet langer toekijken hoe de rest van de wereld crepeert’
Wim Leereveld legt farmaceutische bedrijven langs de meetlat: hoe goed doen zij hun best de minder bedeelden aan medicijnen te helpen? ‘Je moet de Acces to Medicine Index zien als een Michelinster voor de farmacie.’
New Scientist (U.K.)
11 June 2008 New guide to help investors target ethical Pharma
Intermediair (The Netherlands)
18 June 2008 Farmaceuten beoordeeld door pillen-index
Van alle twintig grote farmaceutische bedrijven zet de Engelse multinational GlaxoSmithKline zich het meest in om zijn medicijnen toegankelijk te maken voor ontwikkelingslanden.
Financial Times
16 May 2008 GSK tops league on medicine access
European pharmaceutical companies – led by GlaxoSmithKline – outperform their US peers in efforts to make medicines available and affordable to the poor, according to an analysis.
FEM Business (The Netherlands)
23 February 2008 Stimulerend lijstje
‘Eén tot twee miljard mensen in arme landen hebben geen toegang tot medicijnen. De Nederlander Wim Leereveld denkt een methode te hebben gevonden die grote farmaconcerns ertoe prikkelt die toegang te vergroten.’© FEM Business
Vice Versa (The Netherlands)
1 February 2008 Het wespennest van de Farma-top-twintig
‘De eerste duurzaamheidsindex voor geneesmiddelenfabrikanten zal dit voorjaar een feit zijn. Initiatiefnemer Wim Leereveld wil alle partijen te vriend houden.’
Le Monde (France)
18 December 2007 L’industrie pharmaceutique face aux maladies du Sud
‘Les laboratoires pharmaceutiques se retrouvent aujourd’hui pris en tenaille….’Jean Laville: ‘La création, en 2008, de l’Access to Medicine Indexincitera investisseurs et laboratoires à diffuser de bonnes pratiques’
People Planet Profit (Belgium)
15 December 2007 Dutch initiative: Major investors sign up to Access to Medicine Index
‘Although it is only due to be launched in Spring 2008, ten major international investors have already declared their support for the Access to Medicine Index.’
Het Financieele Dagblad (The Netherlands)
12 December 2007 Grote beleggers geven steun aan index voor toegang tot medicijnen
‘Een aantal grote beleggers heeft deze week officieel steun toegezegd aan de Access to Medicine Index die voorjaar 2008 verschijnt.’
Responsible Investor (UK)
8 November 2007 Investors to rank big pharma on disease prevention
‘Index of pharmaceutical companies and their policies on acces to medicines will begin in spring next year.’
Eurosif Newsflash (France)
17 October 2007 Access to Medicine, a new investor initiative
Ethos (Switzerland)
11 October 2007 Access to Medicine: Ethos participates in a new investor initiative
Access to medicine is one of the main challenges of current development policies. Although it is primarily the responsibility of governments to facilitate access to medicine, pharmaceutical companies nevertheless bear a special responsibility. Aware of the problem, Ethos, together with several institutional investors, supports the «Access to Medicine Index» project in a joint statement.
AGEFI (Switzerland)
11 October 2007 Ethos s'investit dans la cause de l'accès aux médicaments
‘Des médicaments pour tous! Emmenant avec elle ses investisseurs institutionnel et de nombreuses caisses de pension suisses, la fondation Ethos a annoncé hier sa participation….’
Innovator (The Netherlands)
1 September 2007 Index stimuleert bedrijven verantwoord te handelen ten opzichte van ontwikkelingslanden
Manifest-i (UK)
1 April 2007 Socially responsible investment
Access to medicine index to be launched
An index benchmarking the performance of pharmaceutical companies in providing access to their medicines is being developed by the investment research firm, Innovest Strategic Value Advisors, for institutional investors.
Haarlems Dagblad (The Netherlands)
28 March 2007 Niemand wil als eerste buiten de boot vallen
‘De schellen vielen me van de ogen toen ik begreep dat de gemiddelde Afrikaan niet alleen nauwelijks aan de juiste pillen kan komen, maar ook met pijn móet leven…’
CSR Wire (U.S.)
20 March 2007 Breakthrough in Analyzing Access to Medicine Issues: Access to Medicine Index Introduced
Innovest Strategic Value Advisors announced today the successful completion of the first phase of one of its most innovative current projects – the creation of a global Access to Medicine (ATM) Index of major pharmaceutical companies for institutional investors.
Het Financieele Dagblad (The Netherlands)
27 February 2007 Pillenindex voor de armen
‘Een nieuwe index neemt farmareuzen de maat als het gaat om hun pillenbeleid voor arme landen.’
Follow us
Access to Medicine Index
|
Scheepmakersdijk 5A
|
2011 AS
|
Haarlem
|
The Netherlands
|
Phone +31 23 533 91 87
|
info@atmindex.org
|
www.accesstomedicineindex.org